CYP19 siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancerJournal of experimental & clinical cancer research : CRApril 13, 2023Liu L, Mo M, Chen X, Chao D, Zhang Y, Chen X, Wang Y, Zhang N, He N, Yuan X, et al.and reagents Letrozole (T1590) was purchased from TargetMol (Bellingham, WA, USA). CYP19A1 siRNA (sc-41498) and CYP19A1 antibody (sc-374176) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

(2) Downregulation of aromatase plays a dual role in preeclampsiaMolecular human reproductionMarch 24, 2021Zhu D, Huang J, Gu X, Li L, Han J.

(3) Valproic acid-induced histone acetylation suppresses CYP19 gene expression and inhibits the growth and survival of endometrial stromal cellsInternational journal of molecular medicineSeptember 1, 2015Chen Y, Cai S, Wang J, Xu M.The siRNA was synthesized by GenaPharma Co. (Shanghai, China). Briefly, 5 µl of siRNA (CYP19 siRNA, sc‑41498; Santa Cruz Biotechnology, Inc.), 10 µl of Lipofectamine 2000 (Invitrogen) and 245 µl of non‑serum DMEM

CYP19 siRNA (h)